Editorial on "A systematic review of the impact of pulmonary thromboendarterectomy on health related quality of life". [PDF]
Pulm CircPulmonary Circulation, Volume 14, Issue 3, July 2024.
Witkin A.
europepmc +5 more sources
NT-pro-BNP is predictive of morbidity and mortality after pulmonary thromboendarterectomy and is independent of preoperative hemodynamics. [PDF]
Pulm CircCurrent predictors of clinical outcomes after pulmonary thromboendarterectomy (PTE) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) are largely limited to preoperative clinical characteristics.
Keiler EA +10 more
europepmc +3 more sources
Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012-2019). [PDF]
Pulm CircChronic thromboembolic pulmonary hypertension (CTEPH) is a sequela of a pulmonary embolus that occurs in approximately 1%−3% of patients. Pulmonary thromboendoarterectomy (PTE) can be a curative procedure, but balloon pulmonary angioplasty (BPA) has ...
Vohra AS +12 more
europepmc +3 more sources
Anesthetic management of chronic thromboembolic pulmonary hypertension for surgical pulmonary thromboendarterectomy: A narrative review [PDF]
Journal of Anaesthesiology Clinical PharmacologyChronic thromboembolic pulmonary hypertension (CTEPH) is caused due to the total or partial occlusion of the pulmonary vasculature due to organized thrombus, leading to severe pulmonary hypertension and eventually right heart failure, which makes ...
Sambhunath Das, KG Krithika
doaj +3 more sources
Balloon pulmonary angioplasty after pulmonary thromboendarterectomy. [PDF]
Ann Cardiothorac Surg, 2022 .Pulmonary thromboendarterectomy (PTE) is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension (CTEPH) as it can remove the chronic, fibrotic, flow-limiting organized thrombi within the pulmonary arterial bed ...
Palazzini M +6 more
europepmc +6 more sources
Successful pulmonary thromboendarterectomy in a patient with sickle cell disease and associated resolution of a leg ulcer [PDF]
Lung India, 2018 Pulmonary hypertension (PH) is a relatively frequent and severe complication of sickle cell disease (SCD). PH associated with SCD is classified as Group 5 PH. The exact pathogenesis of PH in SCD in not known. There are also very limited treatment options
Abhinav Agrawal +3 more
doaj +5 more sources
Recognizing pulmonary hypertension following pulmonary thromboendarterectomy: A practical guide for clinicians [PDF]
Pulmonary Circulation, 2022 Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary hypertension (PH) arising from pulmonary vascular obstruction at varying levels within the pulmonary vascular bed, due to chronic pulmonary emboli.
Paul Forfia +2 more
doaj +4 more sources
Management of Pulmonary Hemorrhage Complicating Pulmonary Thromboendarterectomy [PDF]
Frontiers in Medicine, 2018 Airway management during pulmonary thromboendarterectomy (PTE) can prove challenging, especially in the face of unexpected intraoperative pulmonary hemorrhage.
Adam A. Dalia +5 more
doaj +5 more sources
Pulmonary thromboendarterectomy in Portugal: Initial experience [PDF]
Revista Portuguesa de Cardiologia, 2020 Introduction: Surgical treatment for chronic thromboembolic pulmonary hypertension (CTEPH) is challenging. Most Portuguese patients with CTEPH have been referred to foreign institutions for treatment, with significant social and economic costs.
José Fragata, Helena Telles
doaj +7 more sources
Quantifying the learning curve for pulmonary thromboendarterectomy [PDF]
Journal of Cardiothoracic Surgery, 2017 Background Pulmonary thromboendarterectomy (PTE) is an effective treatment for chronic thromboembolic pulmonary hypertension (CTEPH), but is a technically challenging operation for cardiothoracic surgeons.
Smita Sihag +7 more
doaj +4 more sources